Last-Hope cancer vaccine offered to patients out of options
NCT ID NCT06963697
Summary
This program provides expanded access to personalized cancer vaccines for patients with solid tumors who have run out of standard treatment options. The vaccine is custom-made to target each patient's specific cancer markers. Eligible patients must have a poor long-term survival outlook and cannot participate in the main clinical trial.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
Locations
-
Texas Oncology
AVAILABLEAustin, Texas, 78705, United States
Contact
Conditions
Explore the condition pages connected to this study.